Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP516479.RAGcWMD8I1kmNERt9c6buNlnDc5i6mIdbaCP-SUNiyxqk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP516479.RAGcWMD8I1kmNERt9c6buNlnDc5i6mIdbaCP-SUNiyxqk130_assertion type Assertion NP516479.RAGcWMD8I1kmNERt9c6buNlnDc5i6mIdbaCP-SUNiyxqk130_head.
- NP516479.RAGcWMD8I1kmNERt9c6buNlnDc5i6mIdbaCP-SUNiyxqk130_assertion wasGeneratedBy ECO_0000203 NP516479.RAGcWMD8I1kmNERt9c6buNlnDc5i6mIdbaCP-SUNiyxqk130_provenance.
- NP516479.RAGcWMD8I1kmNERt9c6buNlnDc5i6mIdbaCP-SUNiyxqk130_assertion wasDerivedFrom befree-20140225 NP516479.RAGcWMD8I1kmNERt9c6buNlnDc5i6mIdbaCP-SUNiyxqk130_provenance.
- NP516479.RAGcWMD8I1kmNERt9c6buNlnDc5i6mIdbaCP-SUNiyxqk130_assertion SIO_000772 11032874 NP516479.RAGcWMD8I1kmNERt9c6buNlnDc5i6mIdbaCP-SUNiyxqk130_provenance.
- NP516479.RAGcWMD8I1kmNERt9c6buNlnDc5i6mIdbaCP-SUNiyxqk130_assertion evidence source_evidence_literature NP516479.RAGcWMD8I1kmNERt9c6buNlnDc5i6mIdbaCP-SUNiyxqk130_provenance.
- NP516479.RAGcWMD8I1kmNERt9c6buNlnDc5i6mIdbaCP-SUNiyxqk130_assertion description "[The type I inositol 1,4,5-trisphosphate (IP(3)) receptor is selectively down-regulated in several neurodegenerative diseases, including Alzheimer's disease, Huntington's chorea, and ischemia, all conditions in which apoptotic neuronal loss occurs.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP516479.RAGcWMD8I1kmNERt9c6buNlnDc5i6mIdbaCP-SUNiyxqk130_provenance.